|
Orthologous residues
|
|
IP3R1 (human): S1598‑p, IP3R1 iso3 (human): S1589‑p, IP3R1 (mouse): S1588‑p, IP3R1 iso2 (mouse): S1573‑p, IP3R1 (rat): S1589‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody
|
|
Relevant cell lines - cell types - tissues:
293 (epithelial), DT40 (B lymphocyte)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
chicken, human
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
forskolin
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
activation
|
|
Comments:
Mutation of site to Glu enhanced, while mutation to Ala inhibited, calcium release through IP3R1.
|